J Korean Diabetes.  2024 Dec;25(4):199-202. 10.4093/jkd.2024.25.4.199.

Remission of Type 2 Diabetes: Can It Be the Goal of Diabetes Treatment?

• Lee MJ

• KMID: 2563236
• DOI: http://doi.org/10.4093/jkd.2024.25.4.199

Abstract

The conventional treatment goals for diabetes have focused on glycemic control to prevent complications, based on the understanding that diabetes is an irreversible chronic condition. However, numerous studies have shown that significant weight loss achieved through intensive lifestyle interventions, low-calorie diets, metabolic surgery, and glucagon-like peptide-1–based medications is associated with a high rate of type 2 diabetes remission. Notably, remission is more likely to occur in the early stages of type 2 diabetes, particularly among younger individuals, those with a shorter duration of the disease, better glycemic control, and greater weight loss. Nevertheless, research on diabetes remission among Asian populations, including those in South Korea, remains limited, and further studies are needed. Additionally, the definition of diabetes remission requires ongoing discussion, emphasizing the need for expert opinions and consensus in this area.

Keyword

Bariatric surgery; Diabetes mellitus, type 2; Early medical intervention; Life style; Weight loss

Reference

1.Buse JB., Caprio S., Cefalu WT., Ceriello A., Del Prato S., Inzucchi SE, et al. How do we define cure of diabetes? Diabetes Care. 2009. 32:2133–5.

2.Karter AJ., Nundy S., Parker MM., Moffet HH., Huang ES. Incidence of remission in adults with type 2 diabetes: the diabetes & aging study. Diabetes Care. 2014. 37:3188–95.

3.Holman N., Wild SH., Khunti K., Knighton P., O'Keefe J., Bakhai C, et al. Incidence and characteristics of remission of type 2 diabetes in England: a cohort study using the national diabetes audit. Diabetes Care. 2022. 45:1151–61.

4.Kirwan JP., Courcoulas AP., Cummings DE., Goldfine AB., Kashyap SR., Simonson DC, et al. Diabetes remission in the alliance of randomized trials of medicine versus metabolic surgery in type 2 diabetes (ARMMS-T2D). Diabetes Care. 2022. 45:1574–83.

5.Klein S., Seeley RJ. Weight versus weight-independent ef-fects of Roux-en-Y gastric bypass on type 2 diabetes. Nat Metab. 2023. 5:912–4.

6.Look AHEAD Research Group., Wing RR., Bolin P., Bran-cati FL., Bray GA., Clark JM., Coday M, et al. Cardiovas-cular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013. 369:145–54.

7.Gregg EW., Chen H., Wagenknecht LE., Clark JM., Delah-anty LM., Bantle J, et al. Look AHEAD Research Group. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA. 2012. 308:2489–96.

8.Lean ME., Leslie WS., Barnes AC., Brosnahan N., Thom G., McCombie L, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-la-bel, cluster-randomised trial. Lancet. 2018. 391:541–51.

9.Taheri S., Zaghloul H., Chagoury O., Elhadad S., Ahmed SH., El Khatib N, et al. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol. 2020. 8:477–89.

10.Sattar N., Welsh P., Leslie WS., Thom G., McCombie L., Brosnahan N, et al. Dietary weight-management for type 2 diabetes remissions in South Asians: the South Asian diabetes remission randomised trial for proof-of-concept and feasibility (STANDby). Lancet Reg Health Southeast Asia. 2023. 9:100111.

11.Al-Mrabeh A., Hollingsworth KG., Shaw JAM., McCon-nachie A., Sattar N., Lean MEJ, et al. 2-year remission of type 2 diabetes and pancreas morphology: a post-hoc analysis of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol. 2020. 8:939–48.

12.Lim EL., Hollingsworth KG., Aribisala BS., Chen MJ., Ma-thers JC., Taylor R. Reversal of type 2 diabetes: normali-sation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011. 54:2506–14.

13.Riddle MC., Cefalu WT., Evans PH., Gerstein HC., Nauck MA., Oh WK, et al. Consensus report: definition and in-terpretation of remission in type 2 diabetes. Diabetes Care. 2021. 44:2438–44.